Targeted Therapies for Attacking Non-Small Cell Lung Cancer with Avanish Vellanki Rain Therapeutics
Released Monday, 29th October 2018
Good episode? Give it some love!
Targeted Therapies for Attacking Non-Small Cell Lung Cancer with Avanish Vellanki Rain Therapeutics
Targeted Therapies for Attacking Non-Small Cell Lung Cancer with Avanish Vellanki Rain Therapeutics
Monday, 29th October 2018
Good episode? Give it some love!
Rate Episode
Avanish Vellanki, Co-Founder and CEO, Rain Therapeutics talks about developing targeted therapies for patients across a range of cancers. Their lead program tarloxotinib is currently being developed for non-small cell lung cancer patients with EGFR/Exon 20 mutations. Avanish fills us in on what makes tarloxotinib so unique, how it has the potential to help patients who currently have no viable treatment options and the future of precision medicine in treating cancers.
@Rain_Thera
Show More
Rate
From The Podcast
Empowered Patient Podcast
Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.Join Podchaser to...
- Rate podcasts and episodes
- Follow podcasts and creators
- Create podcast and episode lists
- & much more
Episode Tags
Do you host or manage this podcast?
Claim and edit this page to your liking.
,Claim and edit this page to your liking.
Unlock more with Podchaser Pro
- Audience Insights
- Contact Information
- Demographics
- Charts
- Sponsor History
- and More!
- Account
- Register
- Log In
- Find Friends
- Resources
- Help Center
- Blog
- API
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More
- © 2024 Podchaser, Inc.
- Privacy Policy
- Terms of Service
- Contact Us